Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Wu, Xiaohong
Sun, Hongfang
and
Liu, Yuanfang
2000.
The conformation alteration of mouse hepatic histones after reacting with nicotinein vitro.
Chinese Science Bulletin,
Vol. 45,
Issue. 9,
p.
825.
Garner, R.C
and
Leong, D
2000.
Pushing the accelerator – speeding up drug research with accelerator mass spectrometry.
Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms,
Vol. 172,
Issue. 1-4,
p.
892.
Sun, H.F
He, L
Liu, Y.F
Liu, K.X
Lu, X.Y
Wang, J.J
Ma, H.J
and
Li, K
2000.
Decay kinetics of nicotine/NNK–DNA adducts in vivo studied by accelerator mass spectrometry.
Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms,
Vol. 172,
Issue. 1-4,
p.
915.
Wang, Haifang
Liu, Yuanfang
and
Sun, Hongfang
2001.
Applications of 14C-AMS for Carcinogen, Pharmaceutical and Nutrient Studies.
Journal of Nuclear and Radiochemical Sciences,
Vol. 2,
Issue. 1-2,
p.
R9.
Cheng, Y.
Li, H.L.
Wang, H.F.
Sun, H.F.
Liu, Y.F.
Peng, S.X.
Liu, K.X.
and
Guo, Z.Y.
2003.
Inhibition of nicotine-DNA adduct formation in mice by six dietary constituents.
Food and Chemical Toxicology,
Vol. 41,
Issue. 7,
p.
1045.
Li, Hongli
Cheng, Yan
Wang, Haifang
Sun, Hongfang
Liu, Yuanfang
Liu, Kexin
and
Peng, Shixiang
2003.
Inhibition of nitrobenzene-induced DNA and hemoglobin adductions by dietary constituents.
Applied Radiation and Isotopes,
Vol. 58,
Issue. 3,
p.
291.
Li, Hongli
Wang, Haifang
Sun, Hongfang
Liu, Yuanfang
Liu, Kexin
and
Peng, Shixiang
2003.
Binding of nitrobenzene to hepatic DNA and hemoglobin at low doses in mice.
Toxicology Letters,
Vol. 139,
Issue. 1,
p.
25.
Wu, William K.K.
and
Cho, Chi Hin
2004.
The Pharmacological Actions of Nicotine on the Gastrointestinal Tract.
Journal of Pharmacological Sciences,
Vol. 94,
Issue. 4,
p.
348.
Ye, Yi N.
Liu, Edgar S. L.
Shin, Vivian Y.
Wu, William K. K.
Luo, Jiing C.
and
Cho, Chi H.
2004.
Nicotine Promoted Colon Cancer Growth via Epidermal Growth Factor Receptor, c-Src, and 5-Lipoxygenase-Mediated Signal Pathway.
Journal of Pharmacology and Experimental Therapeutics,
Vol. 308,
Issue. 1,
p.
66.
Sassen, Andrea W.
Richter, Elmar
Semmler, Marzell P.
Harréus, Ulrich A.
Gamarra, Fernando
and
Kleinsasser, Norbert H.
2005.
Genotoxicity of Nicotine in Mini-Organ Cultures of Human Upper Aerodigestive Tract Epithelia.
Toxicological Sciences,
Vol. 88,
Issue. 1,
p.
134.
Dasgupta, Piyali
Kinkade, Rebecca
Joshi, Bharat
DeCook, Christina
Haura, Eric
and
Chellappan, Srikumar
2006.
Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin.
Proceedings of the National Academy of Sciences,
Vol. 103,
Issue. 16,
p.
6332.
Xu, J.
Huang, H.
Pan, C.
Zhang, B.
Liu, X.
and
Zhang, L.
2007.
Nicotine inhibits apoptosis induced by cisplatin in human oral cancer cells.
International Journal of Oral and Maxillofacial Surgery,
Vol. 36,
Issue. 8,
p.
739.
Zhang, Qunzhou
Tang, Xudong
Zhang, Zuo-Feng
Velikina, Rita
Shi, Shihong
and
Le, Anh D.
2007.
Nicotine Induces Hypoxia-Inducible Factor-1α Expression in Human Lung Cancer Cells via Nicotinic Acetylcholine Receptor–Mediated Signaling Pathways.
Clinical Cancer Research,
Vol. 13,
Issue. 16,
p.
4686.
ZHOU, Qiao-zhi
LIU, Hai-bo
DING, Xin-chun
LI, Peng
ZHANG, Shu-tian
and
YU, Zhong-lin
2007.
Aspirin inhibits the proliferation of tobacco-related esophageal squamous carcinomas cell lines through cyclooxygenase 2 pathway.
Chinese Medical Journal,
Vol. 120,
Issue. 23,
p.
2086.
Seitz, Helmut K.
and
Cho, Chin Hin
2009.
Cancer Epidemiology.
Vol. 472,
Issue. ,
p.
217.
Zeng, Fang
Li, Yun Cheng
Chen, Gang
Zhang, Yong Kui
Wang, Ye Kai
Zhou, Shi Quan
Ma, Li Na
Zhou, Ji Hang
Huang, Yan Yan
Zhu, Wang Yu
and
Liu, Xiao Guang
2012.
Nicotine inhibits cisplatin-induced apoptosis in NCI-H446 cells.
Medical Oncology,
Vol. 29,
Issue. 1,
p.
364.
Wang, Huai
Chen, Lu
Zhou, Tong
Zhang, Zhongwei
and
Zeng, Canwei
2020.
Nicotine Promotes WRL68 Cells Proliferation Due to the Mutant p53 Gain-of-Function by Activating CDK6-p53-RS-PIN1-STAT1 Signaling Pathway.
Chemical Research in Toxicology,
Vol. 33,
Issue. 9,
p.
2361.